During the past decade, Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120" are "Primary Progressive Multiple Sclerosis" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120" in a lesser frequency.

Most popular intervention types in "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tolebrutinib" (2 trials), "Placebo" (1 trials), "Placebo to match Teriflunomide" (1 trials), "Placebo to match Tolebrutinib" (1 trials) and "Teriflunomide HMR1726" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".